Forbes March 25, 2025
DNA-testing pioneer 23andMe faced a reckoning on Sunday — and a whole lot of personal data was left hanging in the balance.
The genetic testing company that once held the vision of unlocking the secrets of our DNA filed for Chapter 11 bankruptcy, its valuation whittled down to a whisper of its former $6 billion peak. Co-founder and CEO Anne Wojcicki resigned, announcing plans to bid on the company herself, following failed attempts to take it private.
When 23andMe launched in 2006, it was positioned as a platform that would revolutionize how people understood their health and heritage, with a mission to “help people access, understand, and benefit from the human genome.”
For $99...
Today's Sponsors
Today's Sponsor